Cargando…
Safety of Biologics for Psoriatic Patients with Latent Tuberculosis
Autores principales: | Yuan, Liyan, Li, Yang, Lin, Junjie, Lin, Xiuqiu, Yang, Bin, Man, Mao-Qiang, Wang, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473411/ https://www.ncbi.nlm.nih.gov/pubmed/37663885 http://dx.doi.org/10.2147/CCID.S426253 |
Ejemplares similares
-
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014) -
Latent tuberculosis
por: Koul, Ajaz Nabi
Publicado: (2016) -
Combination of prealbumin and tuberculosis‐specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection
por: Luo, Ying, et al.
Publicado: (2020) -
Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases
por: Wang, Xiaohua, et al.
Publicado: (2023) -
Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)